Date: 2015-09-08
Type of information: Nomination
Compound:
Company: Cytori Therapeutics (USA - CA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 8, 2015, Cytori Therapeutics announced that Mr. John D. Harris has been appointed as Vice President and General Manager of Cell Therapy, a newly created role to be based in Tokyo, Japan. The role will focus on growth and development of the company’s existing and future global cell therapy commercial operations. Mr. Harris’ start date is set for October 1st, 2015. Mr. Harris joins Cytori from Becton Dickinson, where he serves as President of Becton Dickinson’s Japanese operations, which include a production facility, over 550 employees, and approximately $315 million in revenues. Prior to his current leadership role at Becton Dickinson, Mr. Harris served as the business director of Becton Dickinson’s Medical Systems business unit and shortly thereafter also assumed the lead of the Preanalytical Systems business unit. Prior to joining BD, he functioned in key leadership positions with several healthcare and technology-related companies in the U.S., including Tyco Electronics (Asia Medical Sales Director), Delphi Medical Systems (Global Business Development Manager), and Kimberly-Clark/Ballard Medical Products (Senior Business Development Manager). Mr. Harris speaks fluent Japanese and currently resides in Japan with his wife and children. In addition to his various corporate roles, Mr. Harris is a member of the Board of Governors of the American Chamber of Commerce in Japan (ACCJ) and a member of the Executive Committee of the American Medical Device & Diagnostics Association (AMDD), where he chairs the regenerative medicine working group.
Financial terms:
Latest news:
